| Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside EJ Rahn, AG Hohmann Neurotherapeutics 6 (4), 713-737, 2009 | 372 | 2009 |
| Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats EJ Rahn, A Makriyannis, AG Hohmann British journal of pharmacology 152 (5), 765-777, 2007 | 158 | 2007 |
| Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats EJ Rahn, AM Zvonok, GA Thakur, AD Khanolkar, A Makriyannis, ... Journal of Pharmacology and Experimental Therapeutics 327 (2), 584-591, 2008 | 137 | 2008 |
| Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function AJ Kennedy, EJ Rahn, BS Paulukaitis, KE Savell, HB Kordasiewicz, ... Cell Reports 16, 1-20, 2016 | 124 | 2016 |
| Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memory EJ Rahn, MC Guzman-Karlsson, JD Sweatt Neurobiology of learning and memory 105, 133-150, 2013 | 122 | 2013 |
| Brief report: validation of a definition of flare in patients with established gout AL Gaffo, N Dalbeth, KG Saag, JA Singh, EJ Rahn, AS Mudano, YH Chen, ... Arthritis & Rheumatology 70 (3), 462-467, 2018 | 89 | 2018 |
| Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus EJ Rahn, T Iannitti, RR Donahue, BK Taylor Biology of sex differences 5, 1-18, 2014 | 86 | 2014 |
| A REDCap-based model for electronic consent (eConsent): moving toward a more personalized consent CE Lawrence, L Dunkel, M McEver, T Israel, R Taylor, G Chiriboga, ... Journal of clinical and translational science 4 (4), 345-353, 2020 | 81 | 2020 |
| Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects EJ Rahn, GA Thakur, JAT Wood, AM Zvonok, A Makriyannis, ... Pharmacology Biochemistry and Behavior 98 (4), 493-502, 2011 | 63 | 2011 |
| Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery EJ Rahn, L Deng, GA Thakur, K Vemuri, AM Zvonok, YY Lai, ... Molecular pain 10, 1744-8069-10-27, 2014 | 57 | 2014 |
| Severity of hypertension mediates the association of hyperuricemia with stroke in the REGARDS case cohort study NS Chaudhary, SL Bridges Jr, KG Saag, EJ Rahn, JR Curtis, A Gaffo, ... Hypertension 75 (1), 246-256, 2020 | 47 | 2020 |
| Differential stress induced c-Fos expression and identification of region-specific miRNA-mRNA networks in the dorsal raphe and amygdala of high-responder/low-responder rats JL Cohen, AE Ata, NL Jackson, EJ Rahn, RC Ramaker, S Cooper, ... Behavioural brain research 319, 110-123, 2017 | 40 | 2017 |
| Evaluation of a multimodal, direct‐to‐patient educational intervention targeting barriers to osteoporosis care: a randomized clinical trial MI Danila, RC Outman, EJ Rahn, AS Mudano, DT Redden, P Li, JJ Allison, ... Journal of Bone and Mineral Research 33 (5), 763-772, 2018 | 37 | 2018 |
| Effect of serum urate lowering with allopurinol on blood pressure in young adults: a randomized, controlled, crossover trial AL Gaffo, DA Calhoun, EJ Rahn, S Oparil, P Li, T Dudenbostel, DI Feig, ... Arthritis & Rheumatology 73 (8), 1514-1522, 2021 | 32 | 2021 |
| Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice G Adami, EJ Rahn, KG Saag Therapeutic advances in musculoskeletal disease 11, 1759720X19876468, 2019 | 31 | 2019 |
| Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions W Liu, S Ye, BA Barton, MA Fischer, C Lawrence, EJ Rahn, MI Danila, ... Contemporary clinical trials communications 17, 100474, 2020 | 28 | 2020 |
| Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation EJ Rahn, AM Zvonok, A Makriyannis, AG Hohmann The AAPS journal 12, 147-157, 2010 | 22 | 2010 |
| Lessons learned about harmonizing survey measures for the CSER consortium KAB Goddard, FAN Angelo, SL Ackerman, JS Berg, BB Biesecker, ... Journal of Clinical and Translational Science 4 (6), 537-546, 2020 | 20 | 2020 |
| Education and training of non-genetics providers on the return of genome sequencing results in a NICU setting KM East, ME Cochran, WV Kelley, V Greve, CR Finnila, T Coleman, ... Journal of Personalized Medicine 12 (3), 405, 2022 | 19 | 2022 |
| A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material MI Danila, RC Outman, EJ Rahn, AS Mudano, TF Thomas, DT Redden, ... Contemporary Clinical Trials Communications 4, 14-24, 2016 | 15 | 2016 |
